Super Stock Blog

Let's make our own bull run!

Category: Super Stock (Page 1 of 10)

PayPal for the Long-Term

PayPal (PYPL) recently released earnings and guidance late last week.  The results were excellent and even the guidance showed amazing growth for the upcoming quarter and year ahead.  The CEO and CFO mentioned that on their conference call that the guidance shows a strengthening business outlook moving forward.  PayPal mentioned that Venmo, one of the most popular payment platforms, has grown quite a lot and is now showing revenue instead of just engagement.  The company has purchased multiple e-payment platforms to strengthen their business and grow their bottom line.

However, from last friday-tuesday, the PayPal stock price continued to drop with the FANG stocks.  From a price last week over $92, it has dropped to almost $82 in the past week.  This gives you a nice 10% discount from the current price.  If the tech stocks continue to trend down, PayPal will continue to downtrend with them.  However, I believe PayPal is a strong candidate for long-term growth and I expect it to grow leaps and bounds in the future.

I believe PayPal (PYPL) is a great buy anything below $80 and I expect it to be a nice long-term hold.

DexCom Inc

Dexcom (DXCM) is a company that creates technologies to monitor glucose in people with diabetes.  Their stock price has been in a surge since March going from $55 to be over $100 in the past month.  However, their competitor Abbott (ABT) is interested in their same market and is coming up quick with their own technologies to compete.  Just this morning, Abbott’s new technology FreeStyle Libre was approved by the FDA.

This has dropped Dexcom today to as low as $93 per share.  As a company that specializes in glucose monitoring you know that they are advancing technology just like Abbott but you must also know that they already have their technology out in the marketplace helping diabetes patients through many countries.  They also plan to expand globally to help diabetics throughout the world.  An article on SeekingAlpha mentioned a value of $130 for Dexcom.

I give this stock a price target of $110 which should give you a nice 10% gain from the current price.

NXP Semiconductors

NXP Semiconductors (NXPI) was supposed to be purchased by Qualcomm (QCOM) for a stock share price of $127.50.  It was announced yesterday that if China does not authorize the merger then Qualcomm would walk on the deal and give NXPI a $2 billion break up fee and cancel the merger.  Today, China has not said anything and Qualcomm is walking.

NXP Semiconductor will soon have an extra $2 billion in its bank account.  The current rumor is that the extra money will be used for a big $5 billion buyback or even a special dividend.  Either way, it is great for shareholders especially since the stock has plummetted from over $120 to now an undervalued price at $91.

There is certainly plenty of volatility and even a chance that the stock price will go further down.  However, for the long-term investor, this is a great value.  Yahoo analysts give an average EPS for next year at 7.72.  This is a PE of 11.78 at the current price.  This price is indeed a bargain.

There is plenty of growth moving forward for this company.  In June, NXP Semiconductors introduced semiconductors for use in high powered RF products for 5g networks.  The company also is creating a new line of chips that make it easier for companies building AI tools.  If you just look at the present-day, their embedded chips are already used in factories and automobiles.

With a strong base of current customers using their technologies and a nice set of future chips that will grow the company in the future, there is plenty to get excited about with NXP Semiconductors.  I see this stock as a purchase below $92.  I also believe it will make a nice sell at any price at $120 which should happen in 2-3 years.

Disclosure: I am long NXPI and I purchased today.

Silver Miners vs Silver ETF

I posted an article last week about purchasing ETFS Physical Silver (SILV), a silver ETF, and First Magestic (AG), a silver miner.  There is quite a difference between the two and I would like to explain when it is best to get into both.

First, the silver ETFs follow the silver price.  Some of them hold physical silver like SILV and others purchase silver futures.  I recommend SILV over other silver ETFs like SLV because it has a lower expense ratio.  Since silver prices are quite low and inflation is in the works, I feel that the price cannot go down much lower.  The gold-silver ratio is also over 80 which means there is a higher chance that silver is bottoming out.

Next, I recommended First Magestic (AG).  This is a silver mining stock that is quite low and I do think it is finally hitting a bottom.  There is additional risk in silver miners as a lower silver price means the stock goes down much quicker than silver ETFs.  This also means when the silver price goes up that silver mining stocks can go up to 3x or 4x higher.

I recommend getting into both at this time.  If you don’t like the additional risk, I recommend purchasing the SIVR silver ETF.

High Gold-Silver Ratio and First Majestic

The gold-silver ratio has broken the 80-1 threshold.  This ratio usually implies that the silver price is so low that its time for a reversal which means higher silver prices coming soon.  To play this speculation, I recommend either getting a silver ETF such as SIVR which has the lowest expense ratio or SLV which is a popular silver ETF.  The volatility on both these ETFs are rather low so I don’t see much downside.  I also think if there is a recession or inflation that silver will go up in price.

For those that like leverage, silver miners are a great way to take advantage.  First Magestic (AG) is at a 52-week low and it continues to go lower!  I do think it should be bottoming soon especially if silver prices start rising again.  You do have more risk but if silver prices goes up then this will spike up 3-4 times more than the silver ETFs.

Is NexGen Energy poised to be bigger than Cameco?

Nexgen Energy (NXE) is a recent uranium company that has come into my radar.  I posted numerous times about another company called Energy Fuels Inc (UUUU) but Nexgen Energy appears to be in a better fundamental standpoint.  First, it has discovered multiple uranium deposits and the company continues to find more even the past week.  Second, the uranium deposits are of higher quality than the current mines currently out there.  Third, these deposits are close to the same amounts that Cameco (CCJ) and are poised to overtake the amount of uranium in comparison.

Nexgen Energy is a $750 million cap company while Cameco is a $3.7 billion cap company.  If it were to have equal uranium deposits, there is plenty of growth for Nextgen Energy to grow in the future.  It also recently received $110 million in funding from CEF Holdings.  This company is part of a larger conglomerate of businesses controlled by Li Ka-Shing who also is known as the “asian Warren Buffett”.  He invests in many asian countries and knows the market very well.

China is a energy hungry country that is in process of constructing and completing multiple nuclear plants in the next decade.  Li Ka-Shing knows the market going forward and that uranium will be a necessary commodity for China to fuel their nuclear power plants.  It makes sense that he would accumulate shares in this smaller company that would give him a bigger stake in ownership.  I do believe their is a chance of being acquired in the future but the fundamentals show that Nexgen Energy will have a bullish future ahead as well.

Disclosure: I did recently purchase NXE by selling some of my holdings in UUUU.

Is Akamai in for a dead cat bounce?

Akamai Technologies (AKAM) is the largest cloud technology company that helps businesses deliver cloud delivery content through their high-availability servers across the world.  A few days ago, their stock dropped over 13% when their earnings report was released.  The company did hit their numbers but their guidance was lower than analysts expects.  The stock experienced a major drop in the morning after earnings but the company stock price has been steadily moving up since the release.

One major proponent of the stock is the CEO who has multiple million dollar purchases of the stock.  He believes that the price is too low and started these purchase only this year.

Technically, major stock price drops like this usually follow with a “dead cat bounce” which means this stock will continue with the down trend.  If this happens, expect to get the stock as a cheaper price in the following week.  I am not sure if this is a good long-term stock as Amazon and Facebook have been building out their own hardware to replace Akamai’s services.  However, there are many other businesses that use Akamai including Netflix which will definitely help increase their revenues going forward.

Major Drop in Rite-AID!

There has been a huge sell-off in Rite-Aid (RAD).  A few days ago it was trading at over $4.50 but now it is trading close to $3.80 with more downside expected.  I would not recommend purchasing this stock anymore.  However, there is a great volatility which means there is also great option value in the stock.  Earnings is expected to be on 4/25/17.  This is a serious date that will move Rite-Aid violently up or down.

How to play?

I wouldn’t recommend purchasing the stock.  There’s too much variables in play that can cause this to move higher or lower that would end up making you sell.

Instead, I recommend looking at the August and October Strike price at the $4 or $3.50 to do a naked put.  I see this playing out in two ways.  In scenario one, you will get a nice premium when it sells at $6.50.  You will have collected it when you sold the naked put and now you will be happy that you are done with the stock.  In scenario two, the stock drops further and you end up owning the stock.  In this scenario, you will need to have enough reserves to make sure you can purchase the stock.  Scenario two will require patience and a long-term view that Rite-Aid will go up in the future.  A great earnings report will help prove scenario two as well.

I wouldn’t recommend you getting into this stock today.  I think it is better to give the weekend to plan your attack and due diligence.  Then you can execute your strategy on monday before earnings.  For those that are more conservative, wait until earnings comes out before making your play.  It might end up making more sense to play options after earnings comes out with the volatility playing to your advantage as well.

Disclosure: I do own RAD naked puts at $4 strike currently.

 

 

MMmm… Burgers…. to the Habit

I mentioned in the past article that HABT was a nice pickup at $15.75.  Even before that it had a bottom in the $13.20 but we cannot be all fortune tellers and we need to use the knowledge of both fundamentals and technicals to make our trades.  Now, HABT is trading at at high $17s and I still think it is a great time to get in.

For those that are more conservative, I would wait for the dip.  I cannot tell you I expect a dip to even come with a double-bottom already in place.  For the buy and holds, I expect this to return nicely.  You already saw that Panera Bread was recently bought out for $7 billion dollars to be brought into a privatize institution.

Now is the Right Time for Rite-AID

I’ve been reading about the merger between Walgreens (WAG) and Rite-AID (RAD) since last year.  I never was too interested in taking a position in this merger & acquisition candidate but with the recent sell-off the risk vs. reward is much better now.  I am also more confident in seeing a happy-ending to this scenario.

Originally, Walgreens was going to purchase Rite-Aid at a all-cash offer of $9 per share.  At that time, Rite-Aid was selling for over $6-7 which offered a nice 10% return to investors.  However, FTC didn’t like the deal and told Walgreens that they had to sell more stores to Fred or they won’t allow the purchase to take place.  Walgreens already said agreed to sell 800 stores to Fred.  FTC wants them to sell at least 1000 stores.  This also means that Walgreens will give less cash to Rite-Aid.  After hearing about this news, many investors holding Rite-Aid for over a year awaiting the merger and others holding the stock option gave up and sold their shares.

Now, the current price of Rite-Aid is around $4.50 (give or take a few cents) and Walgreens is planning to give $6.50 to $7.00 cash per share depending on the number of stores they need to divest to Fred.  There are a few different ways to take advantage of this opportunity.

First, Walgreens is actually in a better position.  They can get rid of more stores that they do not want.  Fred is happy to take over these stores since they want smaller stores that Walgreens would consider smaller towns that they are happy to give up and give less money to purchase Rite-Aid.

Second, Rite-Aid stock price is very undervalued now that even other acquirers should start throwing a deal out on Rite-Aid if Walgreens fails to acquire the company.  Rite-Aid does have a lot of debt but for the right investor they could use that debt as a write-off and still win at the current stock price.

Ok, let’s look at the returns.  At a price of $4.60 and a cash out of $6.50,  you are getting $1.90 per share giving you a return of 41%!  That’s great!!  However, if you want to get even more leverage and play a little safer as well, you can sell naked August 2018 Puts at a strike price $4 for around $0.65 so you would get a nice $650 for 10 contracts.  At worse case, the stock drops and you have to purchase at $4 but you already have $.65 so your stock basis would actually be $3.35.  I think this gives you plenty of wiggle room to wait until the stock price appreciations.

I think Walgreens or some other acquirer would be interested in this company.  I also think Rite-Aid can run on its own and figure a solution to get the price higher.  Either way, I feel the current price is a good one to get into Rite-Aid.

Disclosure: I do have naked puts in Rite-Aid currently and plan to purchase some stock for a long-term play.

Page 1 of 10